Work

Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites

Year: 2020

Type: article

Source: The American Journal of Human Genetics

DOI: 10.1016/j.ajhg.2020.08.021

Authors: Michelle R. Jones, Pei-Chen Peng, Simon G. Coetzee, Jonathan Tyrer, Alberto Luiz P. Reyes, Rosario I. Corona, Brian Davis, Stephanie Chen, Felipe Dezem, Ji-Heui Seo, Siddartha Kar, Eileen Dareng, Benjamin P. Berman, Matthew L. Freedman, Jasmine T. Plummer, Kate Lawrenson, Paul Pharoah, Dennis J. Hazelett, Simon A. Gayther

Institutions: Cedars-Sinai Medical Center, University of Cambridge, Dana-Farber Cancer Institute, University of Bristol, MRC Integrative Epidemiology Unit, Hebrew University of Jerusalem, Hadassah Medical Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Cancer Society, Ovarian Cancer Research Alliance, National Institutes of Health, National Cancer Institute

Awards: G1478210804, Genomic and Transcriptomic Analysis of Breast and Ovarian Cancers, G235187537, G3488906442, G4267504860, G5973127094, Identifying causal variants and genes underlying breast cancer risk loci, G78048538, G8452413146, Software Tools For Regulatory Analysis of Large Cancer Methylome Datasets, G9000120924, G9000303521, G9000321312

OpenAlex ID: W3087528483

FWCI: 2.867

Cites: 95

Cited by: 26

Related to: 10